BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 10679014)

  • 1. Characterization of a bone morphogenetic protein-responsive Smad-binding element.
    Kusanagi K; Inoue H; Ishidou Y; Mishima HK; Kawabata M; Miyazono K
    Mol Biol Cell; 2000 Feb; 11(2):555-65. PubMed ID: 10679014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter.
    Ishida W; Hamamoto T; Kusanagi K; Yagi K; Kawabata M; Takehara K; Sampath TK; Kato M; Miyazono K
    J Biol Chem; 2000 Mar; 275(9):6075-9. PubMed ID: 10692396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Hex gene expression by a Smads-dependent signaling pathway.
    Zhang W; Yatskievych TA; Cao X; Antin PB
    J Biol Chem; 2002 Nov; 277(47):45435-41. PubMed ID: 12270938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein-2 (BMP-2) transactivates Dlx3 through Smad1 and Smad4: alternative mode for Dlx3 induction in mouse keratinocytes.
    Park GT; Morasso MI
    Nucleic Acids Res; 2002 Jan; 30(2):515-22. PubMed ID: 11788714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription.
    Li L; Xin H; Xu X; Huang M; Zhang X; Chen Y; Zhang S; Fu XY; Chang Z
    Mol Cell Biol; 2004 Jan; 24(2):856-64. PubMed ID: 14701756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.
    Dennler S; Itoh S; Vivien D; ten Dijke P; Huet S; Gauthier JM
    EMBO J; 1998 Jun; 17(11):3091-100. PubMed ID: 9606191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene.
    López-Rovira T; Chalaux E; Massagué J; Rosa JL; Ventura F
    J Biol Chem; 2002 Feb; 277(5):3176-85. PubMed ID: 11700304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells.
    Bondestam J; Kaivo-oja N; Kallio J; Groome N; Hydén-Granskog C; Fujii M; Moustakas A; Jalanko A; ten Dijke P; Ritvos O
    Mol Cell Endocrinol; 2002 Sep; 195(1-2):79-88. PubMed ID: 12354674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of transforming growth factor beta- and activin-induced transcription by mammalian Mad proteins.
    Chen Y; Lebrun JJ; Vale W
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12992-7. PubMed ID: 8917532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
    Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
    EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis.
    Katagiri T; Imada M; Yanai T; Suda T; Takahashi N; Kamijo R
    Genes Cells; 2002 Sep; 7(9):949-60. PubMed ID: 12296825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads.
    Candia AF; Watabe T; Hawley SH; Onichtchouk D; Zhang Y; Derynck R; Niehrs C; Cho KW
    Development; 1997 Nov; 124(22):4467-80. PubMed ID: 9409665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardiac determination factor, Nkx2-5, is activated by mutual cofactors GATA-4 and Smad1/4 via a novel upstream enhancer.
    Brown CO; Chi X; Garcia-Gras E; Shirai M; Feng XH; Schwartz RJ
    J Biol Chem; 2004 Mar; 279(11):10659-69. PubMed ID: 14662776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and expression of a rat Smad1: regulation by TGFbeta and modulation by the Ras/MEK pathway.
    Yue J; Hartsough MT; Frey RS; Frielle T; Mulder KM
    J Cell Physiol; 1999 Mar; 178(3):387-96. PubMed ID: 9989785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase.
    Kretzschmar M; Liu F; Hata A; Doody J; Massagué J
    Genes Dev; 1997 Apr; 11(8):984-95. PubMed ID: 9136927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.
    Lagna G; Hata A; Hemmati-Brivanlou A; Massagué J
    Nature; 1996 Oct; 383(6603):832-6. PubMed ID: 8893010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the bone morphogenetic protein signaling pathway induces inhibin beta(B)-subunit mRNA and secreted inhibin B levels in cultured human granulosa-luteal cells.
    Jaatinen R; Bondestam J; Raivio T; Hildén K; Dunkel L; Groome N; Ritvos O
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1254-61. PubMed ID: 11889196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse smad8 phosphorylation downstream of BMP receptors ALK-2, ALK-3, and ALK-6 induces its association with Smad4 and transcriptional activity.
    Kawai S; Faucheu C; Gallea S; Spinella-Jaegle S; Atfi A; Baron R; Roman SR
    Biochem Biophys Res Commun; 2000 May; 271(3):682-7. PubMed ID: 10814522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.
    Kurisaki K; Kurisaki A; Valcourt U; Terentiev AA; Pardali K; Ten Dijke P; Heldin CH; Ericsson J; Moustakas A
    Mol Cell Biol; 2003 Jul; 23(13):4494-510. PubMed ID: 12808092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.